MyFinsight
Home
About
Contact
Back
Income Statement
TriSalus Life Sciences, Inc. (TLSI)
source: myfinsight.com
Download
Download image
Net loss
attributable to common...
-$9,002K
(-75.38%↓ Y/Y)
Net loss available
to common...
-$8,288K
(-91.32%↓ Y/Y)
Undeclared dividends on
series a preferred...
$714K
(-10.86%↓ Y/Y)
Income tax benefit
(expense)
-$3K
(-142.86%↓ Y/Y)
Loss before income
taxes
-$8,291K
(-91.70%↓ Y/Y)
Change in fair value of
contingent earnout...
-$700K
(94.89%↑ Y/Y)
Interest income
$134K
(38.14%↑ Y/Y)
Revenue
$11,213K
(52.27%↑ Y/Y)
Change in fair value of
sepa, warrant, and...
-$330K
(96.34%↑ Y/Y)
Interest expense
$1,423K
Loss from operations
-$7,332K
(10.30%↑ Y/Y)
Gross profit
$9,411K
(45.86%↑ Y/Y)
Other expense, net
-$40K
(9.09%↑ Y/Y)
Cost of goods sold
$1,802K
(97.59%↑ Y/Y)
General and
administrative
$5,657K
(43.00%↑ Y/Y)
Research and development
$3,923K
(-15.92%↓ Y/Y)
Sales and marketing
$7,163K
(19.30%↑ Y/Y)
Back